Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 12, 2014

View Archived Issues

Novel genetic variants associated with susceptibility to anorexia nervosa

Novel biological candidate SM-101 shows promise in phase II trials in patient with SLE

FDA grants imiquimod orphan status for carcinoma in situ of the urinary bladder

Liposome encapsulated paclitaxel receives U.S. orphan designation for gastric cancer

Neurocrine Biosciences begins phase I/II trial of NBI-77860

Nihon Medi-Physics patents Abeta imaging agents

International PANACEA study opens in patients with HER2+ breast cancer

Phase II data for sotatercept as treatment of anemia in hemodialysis subjects

PF-06747143: a novel CXCR4 antagonist antibody for the treatment of hematological malignancies

Clinical studies of lucitanib in breast cancer

Karyopharm begins third registration-directed trial of selinexor

Taiho Pharmaceutical divulges PKB inhibitors

Oral Health Australia reports propeptides for periodontal diseases

Novel vinca alkaloids presented by Gedeon Richter

Noribogaine HCl safe and well tolerated in healthy volunteers

Plexxikon and QuantumLeap select PLX-3397 for I-SPY 2 TRIAL in breast cancer

FDA accepts IND application for AGT-182 for the treatment of Hunter syndrome

Pieris begins phase I study of Anticalin to treat anemia

NIHR confirms start of study to test new drug for Sjogren's syndrome

CardioKinetix signs agreement with Edwards Lifesciences

FDA grants conditional approval to Cytori Cell Therapy for trial in scleroderma

FDA approves Quidel's AmpliVue Bordetella Assay

Navidea establishes Macrophage Therapeutics to develop drugs targeting activated macrophages

Lakewood-Amedex submits IND application for phase I/II trial of Nu-3 in diabetic foot ulcer

FDA approves MP Biomedicals' test to confirm HTLV-I/II antibodies

Geneva team pauses VSV-ZEBOV vaccinations following cases of joint pain

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...